DEFERASIROX
| Brand name | DEFERASIROX |
|---|---|
| Active ingredient | DEFERASIROX |
| Strength | 90MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2019 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.